Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors

Overview

Journal J Appl Lab Med

Publisher Oxford University Press

Specialty Biochemistry

Date 2020 Jul 17

PMID 32674118

Citations 3

Authors

Patrick Gutschow

Huiling Han

Gordana Olbina

Keith Westerman

Elizabeta Nemeth

Tomas Ganz

Karen Copeland

Mark Westerman

Vaughn Ostland

Affiliations

Soon will be listed here.

Abstract

Background: Serum markers currently used as indicators of iron status have clinical limitations. Hepcidin, a key regulator of iron homeostasis, is reduced in iron deficiency (ID) and increased in iron overload. We describe the first CLIA-validated immunoassay with excellent accuracy and precision to quantify human serum hepcidin. Its diagnostic utility for detecting ID in first-time blood donors was demonstrated.

Methods: A monoclonal competitive ELISA (C-ELISA) was developed for the quantitation of human hepcidin and validated according to CLIA guidelines. Sera from nonanemic first-time blood donors (n = 292) were analyzed for hepcidin, ferritin, transferrin, and serum iron. Logistic regression served to determine the utility of hepcidin as a predictor of ID.

Results: The C-ELISA was specific for human hepcidin and had a low limit of quantitation (4.0 ng/mL). The hepcidin concentration measured with the monoclonal C-ELISA was strongly correlated with a previously established, extensively tested polyclonal C-ELISA (Blood 2008;112:4292-7) (r = 0.95, P < 0.001). The area under the receiver operating characteristic curve for hepcidin as a predictor of ID, defined by 3 ferritin concentration thresholds, was >0.9. For predicting ID defined by ferritin <15 ng/mL, hepcidin <10 ng/mL yielded sensitivity of 93.1% and specificity of 85.5%, whereas the same hepcidin cutoff for ferritin <30 ng/mL yielded sensitivity of 67.6% and specificity of 91.7%.

Conclusion: The clinical measurement of serum hepcidin concentrations was shown to be a potentially useful tool for diagnosing ID.

Citing Articles

Iron regulatory hormones and their associations with iron status biomarkers among healthy adults of East Asian or Northern European ancestry: A cross-sectional comparison from the Iron Genes in East Asian and Northern European Adults Study (FeGenes).

Barad A, Xu Y, Bender E, Pressman E, Gu Z, OBrien K Am J Clin Nutr. 2025; 121(2):406-416.

PMID: 39909710 PMC: 11863331. DOI: 10.1016/j.ajcnut.2024.10.018.

Effects of iron supplements and iron-containing micronutrient powders on the gut microbiome in Bangladeshi infants: a randomized controlled trial.

Baldi A, Braat S, Hasan M, Bennett C, Barrios M, Jones N Nat Commun. 2024; 15(1):8640.

PMID: 39367018 PMC: 11452624. DOI: 10.1038/s41467-024-53013-x.

Multiple Infections, Nutrient Deficiencies, and Inflammation as Determinants of Anemia and Iron Status during Pregnancy: The MINDI Cohort.

Gonzalez-Fernandez D, Nemeth E, Pons E, Rueda D, Sinisterra O, Murillo E Nutrients. 2024; 16(11).

PMID: 38892681 PMC: 11174717. DOI: 10.3390/nu16111748.

REDD1 deletion and treadmill running increase liver hepcidin and gluconeogenic enzymes in male mice.

Barney Jr D, Gordon B, Hennigar S J Nutr Sci. 2023; 12:e49.

PMID: 37123395 PMC: 10131055. DOI: 10.1017/jns.2023.37.

References

McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B . Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2008; 12(4):444-54. DOI: 10.1017/S1368980008002401. View

Goodnough L, Nemeth E, Ganz T . Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010; 116(23):4754-61. DOI: 10.1182/blood-2010-05-286260. View

Shu T, Jing C, Lv Z, Xie Y, Xu J, Wu J . Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis. Eur J Haematol. 2014; 94(1):67-73. DOI: 10.1111/ejh.12402. View

Cable R, Glynn S, Kiss J, Mast A, Steele W, Murphy E . Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2010; 51(3):511-22. PMC: 3050998. DOI: 10.1111/j.1537-2995.2010.02865.x. View

Thomas C, Kirschbaum A, Boehm D, Thomas L . The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol. 2006; 23(1):23-36. DOI: 10.1385/MO:23:1:23. View

Heeney M, Guo D, De Falco L, Campagna D, Olbina G, Kao P . Normalizing hepcidin predicts mutation status in patients with chronic iron deficiency. Blood. 2018; 132(4):448-452. PMC: 6071554. DOI: 10.1182/blood-2017-03-773028. View

Girelli D, Trombini P, Busti F, Campostrini N, Sandri M, Pelucchi S . A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica. 2010; 96(4):500-6. PMC: 3069225. DOI: 10.3324/haematol.2010.033449. View

Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I . Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med. 2010; 36(6):1044-8. DOI: 10.1007/s00134-010-1794-8. View

Hentze M, Muckenthaler M, Galy B, Camaschella C . Two to tango: regulation of Mammalian iron metabolism. Cell. 2010; 142(1):24-38. DOI: 10.1016/j.cell.2010.06.028. View

10.

Steensma D, Sasu B, Sloan J, Tomita D, Loprinzi C . Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia. Blood. 2015; 125(23):3669-71. DOI: 10.1182/blood-2015-03-636407. View

11.

Armitage A, Drakesmith H . The diagnostic potential of the iron-regulatory hormone hepcidin. Hemasphere. 2022; 3(Suppl). PMC: 8925696. DOI: 10.1097/HS9.0000000000000236. View

12.

Galesloot T, Vermeulen S, Geurts-Moespot A, Klaver S, Kroot J, van Tienoven D . Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood. 2011; 117(25):e218-25. DOI: 10.1182/blood-2011-02-337907. View

13.

van Santen S, van Dongen-Lases E, de Vegt F, Laarakkers C, van Riel P, van Ede A . Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum. 2011; 63(12):3672-80. DOI: 10.1002/art.30623. View

14.

Bregman D, Morris D, Koch T, He A, Goodnough L . Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol. 2013; 88(2):97-101. DOI: 10.1002/ajh.23354. View

15.

Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen B . IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113(9):1271-6. PMC: 398432. DOI: 10.1172/JCI20945. View

16.

Schranz M, Bakry R, Creus M, Bonn G, Vogel W, Zoller H . Activation and inactivation of the iron hormone hepcidin: Biochemical characterization of prohepcidin cleavage and sequential degradation to N-terminally truncated hepcidin isoforms. Blood Cells Mol Dis. 2009; 43(2):169-79. DOI: 10.1016/j.bcmd.2009.03.008. View

17.

Ganz T . Hepcidin and iron regulation, 10 years later. Blood. 2011; 117(17):4425-33. PMC: 3099567. DOI: 10.1182/blood-2011-01-258467. View

18.

Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P . A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2000; 276(11):7811-9. DOI: 10.1074/jbc.M008923200. View

19.

Bergamaschi G, Di Sabatino A, Albertini R, Costanzo F, Guerci M, Masotti M . Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. Inflamm Bowel Dis. 2013; 19(10):2166-72. DOI: 10.1097/MIB.0b013e31829a6e43. View

20.

Pasricha S, Atkinson S, Armitage A, Khandwala S, Veenemans J, Cox S . Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med. 2014; 6(235):235re3. DOI: 10.1126/scitranslmed.3008249. View